BD to acquire Carmel Pharma

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Becton, Dickinson and Company (BD) has signed a definitive agreement to acquire Carmel Pharma, a Swedish company that manufactures the PhaSeal System, a closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

The financial terms of the agreement were not disclosed.

The acquisition, which is expected to close by the end of BD's fiscal year 2011, would expand the scope of the Franklin Lakes, N.J.-based company's healthcare worker safety emphasis, especially in the area of parenteral medication delivery.